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INTRODUCTION
Visual processing occurs as neural coding is transmitted from 
cells of the lateral geniculate nucleus of the thalamus to the primary 
visual cortex (V1, the striate cortex). This is located in the occipital 
lobe calcarine sulcus (Broadmann area 17), where inhibitory and exci-
tatory binocular convergence occurs(1). Cortical synaptic connections 
integrate a fragmented representation of a scene or object, creating 
a recognizable visual perception(2). Color and form are perceived 
through the ventral pathway (parvocellular cells) in the temporal lobe, 
while localization and motion are processed through the dorsal pathway 
(magnocellular cells) in the parietal lobe(3).
Morphophysiologic changes associated with abnormalities of 
visual processing may generate amblyopia, characterized by reduced 
visual acuity and contrast sensitivity either uni- or bilaterally. Patients 
with amblyopia also present with deficits in binocular vision, color, 
and form perception (parvocellular pathway), motion perception 
(magnocellular pathway), and contour integration. There may be 
abnormal function of the fellow normal eye as well. Overall, there is 
di minished capacity to generate a tridimensional representation of 
the world adequate to coordinate manipulation (eye-hand coordina-
tion), reading, and visual decision making(4-8).
Amblyopia has no detectable organic cause(9) but occurs as a re sult 
of visual deprivation (congenital cataracts; ametropia) and/or abnor-
mal binocular interaction (strabismus; anisometropia)(10). Amblyopia 
is the main source of preventable child blindness(11) and of monocular 
vision in 20- to 70-year-old patients(9). The incidence is 1% to 5% in 
children(12), and it accounts for about 60% of vision disorders in preschool 
and school-age children(13). 
Despite the high incidence of amblyopia in children and the fact 
that it affects their cognitive development, school performance, so-
cial integration, and future profession(13,14), its neural basis is relatively 
poorly understood. Investigations have produced apparently conflicting 
results(1,9,15,16). Studies in the last two years have suggested that it is 
essential to discover when the visual deficit took place, that is, in the 
early sensitive period versus late sensitive period(17) to prescribe pro-
per treatment. 
Based on the most recent advances in understanding the neural 
basis of amblyopia, the present article reviews clinical and neurophy-
siologic aspects related to its causes, symptoms, and therapeutic 
approaches. 
Causes 
Ametropia, anisometropia, and strabismus(18) during childhood are 
the most common causes of amblyopia. They result in an abnormal 
visual experience that impairs visual development and processing. 
Development of the visual system is completely dependent on visual 
stimuli(16) that induce elaboration of neural circuits(19). Maturation of 
neural circuits begins at birth, with an early sensitive period at 4 to 18 
months(17) and a late sensitive period to about 7 years of age(15,17). After 
that, there is a significant reduction in neuroplasticity. Until the end of 
Amblyopia: neural basis and therapeutic approaches
Ambliopia: bases neurais e intervenções terapêuticas
Caio César Peixoto Bretas1, renato nery soriano2 
 Submitted for publication: July 11, 2016
 Accepted for publication: August 28, 2016
1 Faculdade de Medicina, Universidade Federal de Juiz de Fora (UFJF), Governador Valadares, MG, 
Brazil.
2 Núcleo de Fisiologia e Biofísica, Departamento de Ciências Básicas da Vida, Universidade Federal 
de Juiz de Fora (UFJF), Governador Valadares, MG, Brazil.
 Funding: No specific financial support was available for this study.
 Disclosure of potential conflicts of interest: None of the authors have any potential conflict of 
interest to disclose.
 Corresponding author: Renato Nery Soriano. Setor de Fisiologia e Biofísica. Departamento 
de Ciên cias Básicas da Vida. Universidade Federal de Juiz de Fora, Governador Valadares, 
MG - 35010-177 - Brazil - E-mail: renato.soriano@ufjf.edu.br 
ABSTRACT
Abnormalities in visual processing caused by visual deprivation or abnormal 
binocular interaction may induce amblyopia, which is characterized by reduced 
visual acuity. Occlusion therapy, the conventional treatment, requires special 
attention as occlusion of the fellow normal eye may reduce its visual acuity and 
impair binocular vision. Besides recovering visual acuity, some researchers have 
recommended restoration of stereoacuity and motor fusion and reverse suppression 
in order to prevent diplopia. Recent studies have documented that the amblyopic 
visual cortex has a normal complement of cells but reduced spatial resolution and a 
disordered topographical map. Changes occurring in the late sensitive period 
selectively impact the parvocellular pathway. Distinct morphophysiologic and 
psychophysical deficits may demand individualization of therapy, which might 
provide greater and longer-lasting residual plasticity in some children. 
Keywords: Amblyopia; Visual acuity; Neural plasticity; Visual cortex
RESUMO
Anormalidades nos processamentos visuais causadas por privação visual ou in­
te ração binocular anormal podem gerar ambliopia, caracterizada por redução 
da acuidade visual. A terapia de oclusão (tratamento convencional) necessita de 
cuidados especiais, pois a oclusão do olho normal (não­amblíope) pode reduzir a 
acuidade visual do mesmo e prejudicar a visão binocular. Além de recuperar a acuidade 
visual, alguns pesquisadores alertam para a necessidade em potencial de se restau­
rar a estereoacuidade e a fusão motora, bem como reverter a supressão a fim de 
impedir diplopia. Estudos recentes revelam que nos córtices visuais de amblíopes há 
uma quantidade normal de células, mas com resolução espacial reduzida e mapa 
topográfico desorganizado. Alterações ocorridas durante o período crítico tardio do 
desenvolvimento visual humano impactam seletivamente a via parvocelular. Déficits 
morfofisiológicos e psicofísicos distintos podem exigir programas de tratamento 
po tencialmente seletivos e poderiam explicar a plasticidade residual maior e mais 
duradoura em algumas crianças. 
Descritores: Ambliopia; Acuidade visual; Plasticidade neuronal; Córtex visual
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the late sensitive period(17) (Table 1), there is macular maturation, optic 
nerve myelination, fusion of images for binocular vision(20), formation 
of the ocular dominance columns in V1 by competition, and matura-
tion of binocular connections by cooperation among afferents from 
both eyes(21). Once past this period, even if the cause of the deficit is 
corrected, an 8- to 10-year-old child is likely to have persistent reduction 
in visual acuity and contrast sensitivity(22).
Ametropia
The most common ametropias are hyperopia, myopia, and astig-
ma tism. Hyperopia is characterized by a refractive error produced 
by a shorter than normal ocular axial length. There is an imbalance 
between refractive capacity and the anteroposterior length of the 
eye(22,23). In a study performed on 37 children 5 to 8 years of age with 
bilateral hyperopia and esotropic amblyopia, it was found that hype-
ropia in the amblyopic eyes was more severe than that of the fellow 
eye(24). In contrast to hyperopia, myopia is a refractive error occurring 
when the anteroposterior ocular axial lenght is longer than normal(22). 
Astigmatism, on the other hand, is detected when the vertical diopter 
value differs from the horizontal value(22). Astigmatism is the most 
common refractive error associated with amblyopia(12) as it substan-
tially affects visual system development(25). The term meridional 
am blyopia is commonly used to refer to amblyopia caused by astig-
matism. Ametropias, therefore, reduce visual acuity(26), generating a 
mild visual deprivation that affects development of the visual system 
in childhood(26). The reported incidence of ametropia as a cause of 
amblyopia is quite high at 62.7%, with 9.4% due to myopia, 21.8% to 
hyperopia, and 31.3% to astigmatism(12,22). 
Anisometropia
Anisometropia is an ophthalmic disorder in which optical measu-
re ments differ between the eyes, which have myopia or hyperopia 
of different degrees and which impairs binocular fusion(22). Variations 
greater than 1.0 diopter (D) in hypermetropic anisometropia or 2.0 D 
in myopic anisometropia are associated with an increased incidence 
of amblyopia(27). Frequent coexistence of anisometropia and amblyo-
pia in the first clinical test in the child and the persistence of reduced 
visual acuity after refractive correction strengthen the evidence that 
anisometropia is a cause of amblyopia(28).
Strabismus
Strabismus, one of the principal ocular deficits in low-income 
children(29,30), is characterized by dysfunction of the extraocular mus-
cles, generating binocular misalignment. The strabismic eye may fail 
to receive visual stimuli onto the macular area(31), thus affecting various 
developmental stages of cortical processing(16). Identification of factors 
that cause strabismus may be important for diagnosis and treatment 
of amblyopia(25).
Congenital cataracts 
Congenital cataracts cause significant visual deficiency and gene-
rate visual deprivation. If cataracts are not surgically treated, they can 
lead to amblyopia(32). This, however, is a less frequent cause(18).
Congenital ptosis
Congenital ptosis (blepharoptosis) refers to an upper eyelid posi-
tioned lower than normal, narrowing the vertical dimension of the 
palpebral cleft(33). Visual deprivation and consequently amblyopia may 
occur if the pupil is covered by the upper eyelid. Studies have shown 
that 6% of patients with congenital ptosis develop amblyopia(34,35), 
called stimulus deprivation amblyopia. 
Diagnosis 
The diagnosis of amblyopia is challenging since there is no specific 
test to detect it, and it depends on the child’s ability to cooperate, po-
tentially compromising the diagnostic process(35). The Snellen chart for 
visual acuity, together with its successors are the main instruments 
used to evaluate visual acuity, that is, high contrast, black-and-white 
recognition acuity.
Possibility of amblyopia should be considered when in the first 
stage of investigation a child presents with visual acuity less than 
20/30 or when the light reflexes in the two eyes are not symmetrical 
and a visual difference between eyes is maintained after correcting 
refractive defects and organic visual defects. Suspicion for amblyopia 
increases if, even after cycloplegic refraction, there is astigmatism 
greater than 2.5 D in both eyes or a ≥1.5 D difference between eyes, 
myopia greater than 5.0 D in both eyes or a ≥3.0 D difference between 
eyes, as well as hyperopia greater than 4.5 D in both eyes or a ≥+1.5 D 
difference between eyes(36).
In addition to using the Snellen chart, it is always important to 
perform a cover test to evaluate ocular alignment. During the clinical 
interview, noting whether the patient had congenital ptosis or cata-
racts and/or refractive defects during childhood is useful to aid in the 
diagnosis of amblyopia.
Strabismic amblyopia is most easily detected by parents. Teachers’ 
contribution is also important to detect amblyopia as early as possi-
ble(37). In Israel and Sweden, screening to detect amblyopia is perfor-
med for school-age children. Ethical concerns have been raised re -
garding this screening, however, as the results may subject children 
to bullying, with an adverse impact on their mental health(38). 
Researchers emphasize the importance of trying to discover the 
age of onset of abnormal visual experience, as this information is 
believed to be essential for choosing specific treatment, at least during 
each of the two sensitive periods of human visual development(17) 
(Table 1).
Table 1. Differences in characteristics of amblyopia and response to treatment by time of onset
Early sensitive period Late sensitive period
Duration 4 to 18 months of agea(17) 18 months to 7 years of agea(17)
Predominant mechanism in binocular connections Competitionb(21) Cooperationb(21)
Ocular dominance columns Under developmentb(46,68) Already developedb(46,68)
Occlusion Hypertrophy of LGNc cells of the non-occluded eye; 
shrinkage of LGN cells of the occluded eyeb(69-71)
Selective shrinkage of cells in the parvocellular 
pathway in both non-occluded and occluded eyesb. 
Normal size of the magnocellular cellsb(69-71)
Functional impairment Parvocellular-related function is more 
diminished in both the amblyopic and  
fellow eyes of early and late onsetd(72)
Parvocellular-related function is more diminished in 
the amblyopic eye of late-onset subjectsd(72)
a= the age ratio of 1:4 has been considered to compare the relative timing in monkey and man, so that 1 week in the monkey is approximately equivalent to 4 weeks in man; b= outcomes 
from studies in monkeys; c= LGN, lateral geniculate nucleus of the thalamus; d= outcomes from human studies. 
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Main treatMents
Conventional treatment of amblyopia consists of occlusion of the 
fellow eye. This tends to augment visual acuity of the amblyopic eye 
and to improve binocular function, as long as it is correctly perfor-
med(39). Treatment schedules vary from months to years(40) but last 3 
years on average(39). American and British guidelines both advise daily 
occlusion for 2 h for moderate and 6 h for severe amblyopia. However, 
10 or more hours have also been reported(40). Occlusion therapy (also 
called patching) should be monitored frequently as to its results(41). 
It can be used in association with other therapeutic modalities(19,40,42). 
Parents’ participation is essential for successful treatment; therefore, 
they should be aware of the necessity, urgency, and potential effec-
tiveness of the therapeutic program(43). 
Despite having been used for many years, occlusion therapy still 
needs to be investigated as to the neural events responsible for rever-
sal of the symptoms(39). Clarification is needed as to what is involved in 
the consolidation of visual neurophysiologic development driven by 
the effects of visual processing using the amblyopic eye. It is believed 
that the neural basis of the treatment is associated with the pheno-
menon of neuroplasticity, an intrinsic capacity to adapt to diverse 
conditions to which the nervous system is submitted. Visual cortex 
plasticity occurs in response to changes in neuronal activity and is 
generated mainly by the action of neuromodulators that promote 
long-term synaptic changes(44). Patching of the fellow eye and visual 
stimuli to the amblyopic eye appear to remodel cortical functions(45). 
Besides functional alterations, patching also induces morphologic 
changes (indicating that there is morphologic plasticity) in cells of 
the retina, lateral geniculate nucleus, and visual cortex (Table 1)(9,46). 
In experimental studies in monkeys, it has been shown that eye 
occlusion by lids suturing at birth and then removal of the sutures at 
the third week of age caused a re-expansion of the ocular dominance 
columns in layer IVcβ of V1, where the afferents to parvocellular cells 
of the lateral geniculate nucleus synapse, and, conversely, a reduction 
of the adjacent columns of magnocellular cells in layer IVcα(46). Hence, 
there is a dissociation between the magno- and parvocellular pathways, 
which may have some effect on visual function. Interestingly, such an 
effect was found only if deprivation and reversal were performed at 
a specific period of visual development(46). These findings raise the 
following question: Would this dissociation between the magno- and 
parvocellular pathways explain why patching is not successful in some 
children with amblyopia?
As mentioned, plasticity in the visual pathways is substantially di-
mi nished as children develop, yet the finding that treatment may be 
partially effective in older subjects with late-onset amblyopia in dicates 
that a certain residual plasticity is present that can reverse or attenuate 
the symptoms of amblyopia after the late sensitive period(17,40,47). As the 
period of greater plasticity varies in different parts of the brain and 
with distinct sensory functions, the period in which it is possible to re-
verse the symptoms caused by visual deprivation may vary as well(40).
Outcomes of treatment vary because of a number of factors. Even 
though there is not yet a consensus on the influence of age on treatment(48), 
studies indicate that treatment initiated after 6 to 8 years of age has 
the lowest success rate(11,19,39,46). Thus, it has been re commended to ini-
tiate treatment as early as possible(48,49), even though 8- to 12-year-old 
chil dren may sometimes satisfactorily respond to therapy(39). The se-
verity of amblyopia also significantly affects treatment outcome, with 
the greatest rate of success found for mild amblyopia(47). Response to 
treatment is a function of initial visual acuity and treatment adheren-
ce(39,50). For example, success in patients with mild amblyopia and 
good adherence to treatment is higher than 80%, whereas it is only 
about 15% in subjects with severe amblyopia and poor adherence(47). 
It is worth pointing out that occlusion treatment requires special 
attention since occlusion of the fellow eye may reduce its visual acuity 
and impair binocular vision. Beyond the visual effects, this may result 
in disturbance of the child’s self-esteem(49) and disruption of the family 
routine. Hence, these factors should be evaluated in each case before 
treatment is prescribed(51). 
Another crucial aspect that deserves attention is that recovering 
visual acuity is only one of the goals of an amblyopia therapy program. 
Other aims are to restore stereoacuity and motor fusion and possibly 
to reverse suppression. Some researchers have warned that if suppression 
is reversed but sensory and motor fusion are not restored, there will 
be a risk of intractable diplopia.
Pharmacological and behavioral forms of treatment in association 
with occlusion therapy tend to reinforce neuroplasticity and ease vi-
sion recovery (Table 2). Patching combined with perceptual learning 
achieves outcomes better than those with occlusion only(40). This asso-
ciation improves visual performance, mainly in binocular(52) and timing(49) 
function and reduces or corrects spatial distortion of images(9). An 
intrinsic difficulty of this treatment is that children must cooperate 
and remain attentive. It is, however, a promising approach for patients 
who have not responded to occlusion alone(52). 
The following drugs have been used in association with occlusion: 
gamma aminobutyric acid (GABA) synthesis inhibitors, citicoline, and 
levodopa (Table 2). It has been shown in animal studies that a GABA 
synthesis inhibitor potentiates cortical plasticity(19). Citicoline, an in-
termediate in acetylcholine and phospholipids biosynthesis, appears 
to ameliorate visual acuity by favoring action potential conduction, 
but its long-term effects need to be evaluated(48). Levodopa, a dopa-
mine precursor used in treating Parkinson disease, ameliorates visual 
function of patients with irreversible amblyopia. It is believed that 
le vodopa is capable of restoring visual neuroplasticity, although it is 
remains to be verified if this is a long-lasting effect(53).
As a form of treatment independent of occlusion, some studies have 
reported the use of atropine (Table 2), a parasympatholytic muscarinic 
antagonist. Atropine may help in treating moderate amblyopia(29), 
as it interferes with visual accommodation of the fellow normal eye, 
thus indirectly forcing use of the amblyopic one(19). However, atropine 
treatment is not always effective(48). Less conventional treatments such 
as refractive therapy, acupuncture, and others have also been des-
cribed(54). Randomized, controlled trials of treatment modalities for 
amblyopia are necessary. 
According to some authors, experimental evidence reveals that 
abnormal visual experience can both extend(55,56) and reduce(57) plasti-
city. This may be a significant observation for amblyopia treatment 
because such children had abnormal visual experiences before being 
treated. This may account for the variability and unpredictability of 
the response to occlusion(58), positive response in some children(59), relati-
vely low incidence of amblyopic children with non-treated, early-onset 
strabismus(60) in comparison to those with congenital cataracts.
neural basis 
Significant advances in understanding the neural basis of am-
blyopia are plausibly associated with development of more effective 
therapeutic approaches. As of the middle of the last year (2015), gaps 
in science-based knowledge about the neural basis of amblyopia still 
existed, and some aspects remained controversial and were a matter 
of debate.
Although it is not expected that the classical psychophysical de-
ficits in amblyopia, such as loss of contrast sensitivity at high spatial 
fre quencies, spatial distortion, mislocalization, and reduced sensitivity 
for form and motion, may be understood from a single model or ex-
planation, some recent findings shed new light on the neural basis of 
amblyopia. 
An important aspect for understanding the cortical deficits in 
pa tients with amblyopia is the possible reduction in the number of 
cortical neurons stimulated by foveal projections, which would induce 
loss of contrast sensitivity and mislocalization. It is believed that the 
visual impairment could therefore be explained at least partially by 
a reduced complement of cortical cells excited by the amblyopic 
projections(61) or because cortical magnification would be reduced(62) 
(Table 3). 
Some intriguing questions have been raised in the literature: Would 
V1 dysfunction be a consequence of loss of binocularity of cortical cells, 
Bretas CCP, soriano rn
349Arq Bras Oftalmol. 2016;79(5):346-51
or would impairment of excitation-inhibition balance exist in bi nocular 
cells? Some researchers have speculated that cellular interactions in 
amblyopia are reduced in intensity, whereas others think that sensi-
tivity and spatial resolution are both reduced in cortical neurons sti -
mulated by foveal projections(63). Furthermore, it has been speculated 
that the cortical deficits would not necessarily occur in V1(64); perhaps 
the problem might lie only in V2 and V3, with normal processing 
in V1(65). The following hypothesis has also been proposed in the li -
terature: The amblyopic projections are disordered, and there is a 
significant reduction (or loss) of spatial resolution of cortical neurons 
stimulated by projections from the fovea, which is thicker in subjects 
with amblyopia when evaluated by optical coherence tomography(1). 
It remains to be investigated whether thickening of the fovea directly 
influences visual acuity, whether it is associated with worse visual 
progn osis, and whether intensive early intervention is capable of 
controlling or preventing such thickening.
Guided by simulations of how different types of cellular disturban-
ces (e.g., loss of cells’ spatial resolution, increased cellular disarray, and 
reduced cellular sampling) would affect the neuronal population 
receptive field, researchers have used functional magnetic resonance 
imaging to analyze population receptive fields in V1 (striate cortex), 
V2 and V3 (extrastriate cortex) of humans with moderate-to-severe 
am blyopia(4). The model regularly samples responses at the voxel le-
vel from a dense array of receptive fields. Hence, it forecast the effects 
of the size of the population receptive field versus eccentricity and 
also the effects of eccentricity versus cortical distance, which reflects 
cortical magnification(4). 
Substantial evidence now supports the contention that the defi-
cits in visual processing are also found in V2 and V3, and that these are 
not a consequence of abnormal processing occurred in V1(4) (Table 3). 
It is conceivable that patients with amblyopia possess an immature 
visual system with a normal complement of cells, i.e., the quality of 
global cortical topographical representation of information from the 
amblyopic eye is preserved and, therefore, there is no reduction in 
the number of cells excited(61). Moreover, cortical magnification is not 
reduced as believed(62) but is normal(4) (Table 3). Although this last con-
clusion may be contested by those who propose that the amblyopic 
eye would activate fewer neurons, hence generating a reduced sample, 
the counterargument is supported by data revealing that a reduced 
cortical sample alone would not induce changes in the size of popu-
lation receptive fields(4) and thus cannot be the only explanation.
Interestingly, although subjects with amblyopia have a normal 
com plement of cells, population receptive fields are enlarged in V1 
and even more so in V2 and V3. Enlarged population receptive field 
might be consequence of unstable movement of the amblyopic eye(66), 
but such a possibility can be discarded due to the methodo logical 
criteria adopted(4). Another possibility is that an enlarged po pulation 
receptive field may be a result of a reduced contribution of smaller 
population receptive fields for the amblyopic eye projections. Even 
though this last proposal sounds plausible, another relevant finding 
explains that enlarged population receptive fields is the di sordered 
topographical map(4) derived from increased positional disarray of cells 
(Table 3). 
There are important questions that have not yet been addressed. Is 
spatial resolution reduced in amblyopic cortical cells? Do subjects with 
amblyopia experience spatial distortions and reduced positional accu-
racy as a function of reduced or lost spatial resolution? The response to 
this question seems to be indicated by findings that show greater posi-
tional variability is found in amblyopic population receptive fields(4,67). 
Taken together, the recent advances in understanding the neural 
basis of amblyopia reveal that patients with amblyopia exhibit a normal 
complement of cells whose spatial resolution is reduced and topo-
graphical map is disordered (Table 3). 
Final reMarks
Visual abnormalities vary with different types of abnormal visual 
experience and the age of onset. Children with amblyopia having si-
milar visual acuity may exhibit very distinct morphophysiologic varia-
tions and distinct visual functions. These anatomical and psychophy-
sical differences, besides accounting for greater and longer-lasting 
plasticity in some children, may require special treatment programs 
in order to improve therapeutic effectiveness. Therefore, combining 
subjects with early- and late-onset amblyopia in research studies is 
not recommended. 
Given that binocular function may affect plasticity, it is very im-
portant in the diagnosis and treatment of amblyopia to detect the 
presence or absence of binocularity. It should be investigated whether 
the loss of binocular function was subsequently followed by a re-
duction of visual acuity or if abnormal monocular afferent signals first 
reduced visual acuity with a subsequent loss of binocularity. In many 
children, amblyopia develops at an age in which the ocular domi-
nance columns of V1(46,68) are no longer affected, i.e., after the early 
sen sitive period (Table 1). It has been documented that morphologic 
changes occurring during the late sensitive period selectively affect 
cells of the parvocellular pathway(17,21,69-71). It seems reasonable to 
re commend that treatment for amblyopia should be individualized, 
as some children with amblyopia may not respond to occlusion be-
cause of morphophysiologic dissociation between the magno- and 
parvocellular pathways(72). 
Table 2. Main treatments for amblyopia: neurophysiologic effects and disadvantages
Treatment Neurophysiologic effects Disadvantages
Occlusion Stimulates amblyopic eye, improving its  
visual acuity by plasticity(40)
Reduces binocular function(32), changes family routine(49),  
may induce psychological problems(32). Adherence varies(26,31)
Occlusion + perceptual learning Improves binocular, spatial, and timing functions(32) Requires the child’s attentiveness and cooperation(50)
Occlusion + levodopa Increases cortical plasticity(33) Long-term outcomes need to be monitored(33)
Occlusion + citicoline Improves action potential conduction(33) Long-term outcomes need to be monitored(33)
Atropine Prevents fellow normal eye accommodation, 
stimulating the amblyopic one(45)
Occlusion outcomes are faster(45)





Complement of cells Normal Normal
Spatial resolution Reduced Reduced
Cortical magnification factor Normal Normal
Topographical map Disordered Very disordered
Population receptive field size Enlarged Very enlarged
*= results from population receptive field functional magnetic resonance imaging analysis(4).
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